Search:        

Building Block banner
(2-(6-hydroxy-2-oxo-2,3,4,5-tetrahydropyridin-3-yl)-3-oxoisoindolin-5-yl)methyl hydrogen (2-fluoro-5-(trifluoromethoxy)phenyl)carbonimidate
Chemical Name: (2-(6-hydroxy-2-oxo-2,3,4,5-tetrahydropyridin-3-yl)-3-oxoisoindolin-5-yl)methyl hydrogen (2-fluoro-5-(trifluoromethoxy)phenyl)carbonimidate Catalog: 201337208
CAS Number: 2803881-11-8 Purity: 96.0% min
Package: 5g,10g,25g,100g,500g,1kg,5kg,10kg Price: POA
Lead Time: Typically in stock

Contact information

We sincerely hope that our Building Blocks can effectively streamline your R&D processes and significantly accelerate the pace of your research and development. Should you have more compounds that need to be custom made, please fell free to contact me via inquiry@pharmacore.cn

Recommended products

  • 1-(Diphenylphosphino)-N,N-dimethyl-1H-inden-2-amine

    201338092

    1-(Diphenylphosphino)-N,N-dimethyl-1H-inden-2-amine

  • (R)-1-{(R)-2-[Bis[3,5-bis(trifluoromethyl)phenyl]phosphino]ferrocenyl}ethyldi(3,5-xylyl)phosphine

    190910016

    (R)-1-{(R)-2-[Bis[3,5-bis(trifluoromethyl)phenyl]phosphino]ferrocenyl}ethyldi(3,5-xylyl)phosphine

  • (S,S)-(-)-2,2-Bis[(R)-(N,N-dimethylamino)(phenyl)methyl]-1,1-di[bis(3,5-trifluoromethylphenyl)phosphino]ferrocene

    201338078

    (S,S)-(-)-2,2-Bis[(R)-(N,N-dimethylamino)(phenyl)methyl]-1,1-di[bis(3,5-trifluoromethylphenyl)phosphino]ferrocene

  • (1Rp,1Rp)-1,1-Bis[bis[3,5-bis(trifluoromethyl)phenyl]phosphino]-2,2-bis[(S)-(dimethylamino)phenylmethyl]ferrocene

    201323325

    (1Rp,1Rp)-1,1-Bis[bis[3,5-bis(trifluoromethyl)phenyl]phosphino]-2,2-bis[(S)-(dimethylamino)phenylmethyl]ferrocene

  • 1,1-Bis((R)-dimethylamino)(phenyl)methyl)ferrocene

    201324228

    1,1-Bis((R)-dimethylamino)(phenyl)methyl)ferrocene

  • (S)-3-(4-Fluoro-1-oxoisoindolin-2-yl)piperidine-2,6-dione

    190914453

    (S)-3-(4-Fluoro-1-oxoisoindolin-2-yl)piperidine-2,6-dione

Copyright @ PHARMACORE CO.,LIMITED. Our products are listed related to patents, for research purposes only, no commercial sales.

Back to the top